Cl. 5: Therapeutic pharmaceuticals for the treatment of cardiovascular disease, arterial disease, and atherosclerosis · Cl. 42: Research and development of therapeutic pharmaceuticals for the treatment of cardiovascular disease, arterial disease, and atherosclerosis
Bitterroot Bio, Inc.
Especificação: Cl. 5: Therapeutic pharmaceuticals for the treatment of cardiovascular disease, arterial disease, and atherosclerosis · Cl. 42: Research and development of therapeutic pharmaceuticals for the treatment of cardiovascular disease, arterial disease, and atherosclerosis
